focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,195.00
Bid: 1,199.00
Ask: 1,201.00
Change: 4.00 (0.34%)
Spread: 2.00 (0.167%)
Open: 1,192.00
High: 1,206.00
Low: 1,176.00
Prev. Close: 1,191.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

20 May 2021 07:00

RNS Number : 2023Z
Fevertree Drinks PLC
20 May 2021
 

Fever-Tree Drinks plc

TRADING UPDATE

 

Fever-Tree, the world's leading supplier of premium carbonated mixers, announces a trading update ahead of its Annual General Meeting ("AGM"), which is being held today at 11.30am BST.

Our Off-Trade performance has remained strong in the first four months of the year. While we would expect some of this demand to switch to the On-Trade as restrictions ease further, it is clear that at-home consumption of long mixed drinks is becoming increasingly established, supported by both the retailers and spirit companies. While the pace of the On-Trade reopening is going to vary between markets, our brand strength and the relationships we have with our On-Trade partners makes us well placed to benefit from its return over the rest of the year.

UK

The phased reopening of the On-Trade has given the hospitality industry renewed optimism for the second half of 2021. On-Trade outdoor spaces in England reopened on 12th April, where we estimate that about a third of venues were able to re-open at reduced capacities, followed by the return of indoor space three days ago on 17th May. Whilst it remains too early to predict the pace of On-Trade recovery this year, Fever-Tree's brand strength, distribution footprint and strong relationships with our customers means we are well positioned to take advantage of the return of this important channel, which represented about 50% of UK revenue pre-COVID.

Fever-Tree's Off-Trade performance has been strong since the start of the year. Sales in the 13 weeks ending 18 April were up 10.1% year-on-year[1], this is despite lapping the effects of stockpiling seen at the beginning of the first lockdown in March 2020. This performance was ahead of the total mixer category, indicating the strength of the brand, the success of the new flavours and formats which we launched last year, and the marketing campaigns we have continued to invest in.

US

The On-Trade has been re-opening on a State-by-State basis in the US, with domestic tourism slowly returning but international tourism and larger events likely to take longer to return. Despite the closure of this channel for most of 2020, Fever-Tree managed to secure a number of new national accounts, positioning us well within this channel as it continues to reopen during 2021 and beyond.

Fever-Tree's Off-Trade sales have continued to perform strongly at the start of 2021, increasing by 38.2% year-on-year in the 12 weeks to 27th March[2] which was ahead of the wider mixer category, and includes approximately 3-4 weeks where we started to lap the large stockpiling effect from last year. Fever-Tree's strong performance not only reflects increased at-home consumption, but also the uplift in trial and repeat purchase we have secured as a result of the pricing optimisation undertaken in 2020.

We have made good progress with our innovation and marketing in the first few months of the year, successfully launching our Lime and Yuzu Soda, which has received strong initial trade interest, as well as securing our first listing on a US airline, with our Indian Tonic and Club Soda 150ml cans now available on all Delta domestic and international flights.

Europe

The On-Trade remains materially impacted in many markets, but confidence is improving as it's anticipated that restrictions will ease over the coming months. Recovery in Europe is likely to lag the UK and US, however, Fever-Tree's prevailing brand strength, increasing local presence, and the market trends towards premiumisation continue to position us very strongly as we look to the long-term opportunity ahead in the region.

The Group has continued its encouraging progress in the Off-Trade, building on the strong sales and value share gains during 2020 across our key markets. Retailers are looking to benefit from the category's value growth and the acceleration of premium serves, working with Fever-Tree and spirit brands to create promotional displays in store to drive these trends further.

ROW

Fever-Tree has continued to build on the strong progress made in the region during 2020, with our position as the clear premium mixer category leader in our two key markets, Australia and Canada, growing during the first part of 2021.

In Australia, where the On-Trade has now been open for a few months, we have seen a good recovery in suburban areas, with city centre demand taking longer to return. Fever-Tree's progress in the Off-Trade remains strong as we drive the premium mixer category in both grocery and liquor channels.

FY21 outlook

We remain committed to investing in the future opportunity for the brand across all our regions, enabled by the Group's strong balance sheet and conviction in our ability to deliver long-term sustainable growth. The continuation of restrictions relating to the pandemic, along with increasing logistics cost pressures have affected us, alongside the whole industry for the first four months of the year. Despite these sustained impacts, we have delivered a strong sales performance and are trading in line with the Board's expectations for the full year to 31 December 2021, assuming levels of uncertainty surrounding the pandemic continue to subside.

For more information please contact:

Investor queries

Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)7435 828 138

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

 

Nominated Advisor and Joint Broker - Numis Securities

Garry Levin I Matt Lewis I Hugo Rubinstein I +44 (0)20 7260 1000

Joint Broker - Investec Bank plc

David Flin I Alex Wright I +44 (0)20 7597 5970

Financial PR advisers - Finsbury

Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0) 7826 534 233; Amanda Healy +44 (0)7795 051 635

 

[1] IRI 13 weeks ending 18 April 2021

[2] Nielsen

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKSNFAXFEFA
Date   Source Headline
19th Apr 202110:26 amRNSHolding(s) in Company
7th Apr 202111:55 amRNSTotal Voting Rights
7th Apr 20217:00 amRNSHolding(s) in Company
18th Mar 20217:00 amRNSFY20 Preliminary Results to 31 December 2020
1st Mar 20217:00 amRNSTotal Voting Rights
2nd Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSFY20 Trading Update
4th Jan 20211:43 pmRNSTotal Voting Rights
1st Dec 20207:00 amRNSTotal Voting Rights
30th Nov 20207:00 amRNSBlock Listing Return
27th Nov 20203:10 pmRNSHolding(s) in Company
2nd Nov 20207:00 amRNSTotal Voting Rights
1st Oct 20207:00 amRNSTotal Voting Rights
18th Sep 202010:30 amRNSHolding(s) in Company
15th Sep 20201:39 pmRNSDirector/PDMR Shareholding
11th Sep 20209:21 amRNSDirector/PDMR Shareholding
8th Sep 20207:00 amRNSHalf-year Report
1st Sep 202011:07 amRNSTotal Voting Rights
4th Aug 20202:16 pmRNSTotal Voting Rights
14th Jul 20207:00 amRNSTrading Statement
3rd Jul 202011:38 amRNSTotal Voting Rights
18th Jun 202012:36 pmRNSTR1: Notification of Major Holdings
9th Jun 20205:02 pmRNSBlock Listing Return
4th Jun 20203:58 pmRNSResult of AGM
4th Jun 20207:00 amRNSAGM STATEMENT & COVID-19 UPDATE
28th May 20205:00 pmRNSGrant of Options
11th May 20204:37 pmRNS2019 Annual Report and Notice of AGM
29th Apr 20207:00 amRNSDirectorate Change
28th Apr 20204:13 pmRNSTR1: Notification of Major Holdings
23rd Apr 202012:15 pmRNSDirector/PDMR Shareholding
22nd Apr 20207:00 amRNSPreliminary Results
14th Apr 20202:30 pmRNSNotification of Results
8th Apr 20204:14 pmRNSStandard form for Notification of Major Holdings
23rd Mar 202010:59 amRNSFCA letter re Release of Preliminary Results
27th Feb 20207:00 amRNSNotification of Major Holdings
11th Feb 20206:04 pmRNSTR-1: Notification of Major Holdings
10th Feb 20207:00 amRNSDirector/PDMR Shareholding
28th Jan 20205:23 pmRNSTR1: Notification of Major Holdings
23rd Jan 20204:34 pmRNSTR-1: Notification of major holdings
23rd Jan 20207:00 amRNSDirector/PDMR Shareholding
22nd Jan 20204:35 pmRNSTR-1: Notification of major holdings
22nd Jan 202012:15 pmRNSTR-1: Notification of major holdings
20th Jan 20207:00 amRNSYear End Trading Update
8th Jan 20202:19 pmRNSNotification of major holdings
3rd Jan 20203:31 pmRNSTR-1: Standard form notification of major holdings
29th Nov 20197:00 amRNSDirector Disclosure
20th Nov 20197:00 amRNSTrading Update
18th Nov 20197:00 amRNSDirector/PDMR Shareholding
6th Nov 20195:43 pmRNSBlock Listing Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.